SOMAREALITY’s €3M raise brings eye-tracking biomarkers closer to real-world use
SOMAREALITY raised over €3M to scale eye-tracking algorithms for real-time cognitive monitoring, pointing to new applications in healthcare and human-performance data.
Eye tracking is moving beyond research labs. SOMAREALITY’s raise shows how cognitive monitoring could become a practical data layer across health, performance and safety use cases.
What happened
Vienna-based SOMAREALITY secured over €3M in an oversubscribed Series A.
The company uses eye-tracking algorithms to measure cognitive states in real time, including cognitive load, attention, perception and fatigue.
Why it matters
This is an interesting healthtech and deeptech crossover.
Cognitive state is difficult to measure directly, but eye movement can provide useful signals. If the technology becomes reliable and easy to deploy, it could support healthcare, aviation, sports, training and workplace safety applications.
The bigger picture
The broader healthtech market is moving toward more continuous and contextual data.
SOMAREALITY fits that trend by turning eye-tracking into a possible real-time biomarker layer. The opportunity is early, but the product is differentiated enough to watch.